aap Implantate AG
Deutsche BörseTotal Valuation
aap Implantate AG carries a market capitalization of 23.69M, placing it among publicly traded companies globally. Its enterprise value stands at 19.78M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 23.69M |
| Enterprise Value | 19.78M |
Share Statistics
aap Implantate AG currently has 3.48M shares outstanding.
| Shares Outstanding | 3.48M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 2.49, and the price-to-book ratio stands at 14.24.
| PE Ratio | N/A |
| PS Ratio | 2.49 |
| PB Ratio | 14.24 |
| P/TBV Ratio | 1.40 |
| P/FCF Ratio | -9.30 |
| P/OCF Ratio | -5.19 |
Enterprise Valuation
| EV / Sales | 1.75 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
aap Implantate AG maintains a current ratio of 4.13, meaning it holds 4.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.13 |
| Quick Ratio | 1.77 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | -188.24 |
| Return on Assets (ROA) | -18.90 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.07 |
Taxes
| Income Tax | 259,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
aap Implantate AG's stock has declined approximately -13.44086% over the past 52 weeks. The 50-day moving average sits at 1.93, while the 200-day moving average is 1.58.
| Beta (5Y) | N/A |
| 52-Week Price Change | -13.44086% |
| 50-Day Moving Average | 1.93 |
| 200-Day Moving Average | 1.58 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, aap Implantate AG generated 11.32M in revenue and converted that into -8.47M in net income, yielding earnings per share of -2.58. EBITDA reached -8.53M, while operating income came in at -8.53M.
| Revenue | 11.32M |
| Gross Profit | 10.73M |
| Operating Income | -8.53M |
| Pretax Income | -8.21M |
| Net Income | -8.47M |
| EBITDA | -8.53M |
| EBIT | -8.53M |
| Earnings Per Share (EPS) | -2.58 |
Balance Sheet
Total book value stands at 1.98M, with working capital of 14.81M providing operational flexibility.
| Cash & Cash Equivalents | 8.36M |
| Total Debt | N/A |
| Net Debt | -5.16M |
| Equity (Book Value) | 1.98M |
| Book Value Per Share | 0.60 |
| Working Capital | 14.81M |
Cash Flow
aap Implantate AG produced -5.43M in operating cash flow over the past twelve months. After subtracting -2.39M in capital expenditures, free cash flow totaled -7.82M - equivalent to -2.39 per share.
| Operating Cash Flow | -5.43M |
| Capital Expenditures | -2.39M |
| Free Cash Flow | -7.82M |
| FCF Per Share | -2.39 |
Margins
aap Implantate AG operates with a gross margin of 94.75, reflecting its pricing power and cost economics. The operating margin of -75.34 and net profit margin of -74.82 provide insight into operational efficiency.
| Gross Margin | 94.75 |
| Operating Margin | -75.34 |
| Pretax Margin | -72.54 |
| Profit Margin | -74.82 |
| EBITDA Margin | -75.34 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -14.81 |
| FCF Yield | -10.75 |
Stock Splits
aap Implantate AG's most recent stock split took place on September 30, 2021 with a 200:217 split ratio.
| Last Split Date | 9/30/2021 |
| Split Ratio | 200:217 |
Scores
aap Implantate AG posts an Altman Z-Score of 0.40, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.40 |